IPO - Profile


Our mission is to change the world, one protein at a time. We founded Absci with the goal of creating better medicines and helping them reach patients sooner. We recognized the extraordinary medical and economic potential of protein-based drugs (biologics), but also the significant challenges the biopharmaceutical industry faces to both discover novel biologics and generate cell lines to manufacture them at commercial scale. We looked at the end game – getting better medicines to patients, faster — and asked: how? We built our technology to be that how.

We believe More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$16.00 12,500,000 Positive High 20.36%

Offering Team

  • Legal counsel
  • Goodwin Procter LLP
  • Auditors
  • Ernst & Young LLP

Deal Highlights

Deal Tracker

IPO Dates

Filing 21 Jul, 2021

Offer 22 Jul, 2021

Look Ahead

Lock Up Expiry Jan 22, 2022

IPO Terms

Offer Price $16.00
Offer Size 12M

Market Sentiments

Stock Price